Hyperplasia and endometrial precancer
https://doi.org/10.17650/1994-4098-2011-0-4-59-63
Abstract
Hyperplastic process is nothing but excessive proliferation determining by histological or cytological method. Extending of the
precancer" conception including not only atypical endometrial hyperplasia but also other pathological changes of the endometriu m (glandu- lar-cystic hyperplasia, polyposis), with the marked endocrine and metabolic disorders background is of some scientific interest and encour- ages a search for a wide range of hypothetical pathogenetic mechanisms and w ays to prevent precancer and endometrial cancer . However, such an extension of the view on the endometrial precancer is not an equivalent of the nosological diagnosis which involves anexact morpho- logic substrate of the pathological process and a specific treatment policy.
About the Authors
O. A. GornikhRussian Federation
V. V. Samoilenko
Russian Federation
A. K. Bishtavi
Russian Federation
A. A. Kanibolotsky
Russian Federation
I. B. Manukhin
Russian Federation
U. U. Tabakman
Russian Federation
References
1. Sivridios E., Giatromanolaki A. The endometrial hyperplasias revisited. Virch Arch 2008;453:223–31.
2. Чепик О.Ф. Морфогенез гиперпластических процессов эндометрия. Практ онкол 2004;5(1):9–15.
3. Перельмутер В.М. Морфологические изменения эндометрия при гиперплазии и эндометриальной интраэпителиальной неоплазии. Сиб онкол журн 2008; 5(29):5–10.
4. Кондриков Н.И., Силакова А.В. Гиперпластические изменения и предраковые состояния эндометрия: вопросы терминологии и классификации. Арх патол 2010;72(1):60–2.
5. Kurman R.J., Norris H.J. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982;49:2547–57.
6. Kurman R.J., Kaminski P.F., Norris H.J. The behavior of endometrial hyperplasia: A long-term stady of “untreated” hyperplasia in 170 patients. Cancer 1985;56:403–12.
7. Новикова Е.Г., Чулкова О.В., Пронин С.М. Лечение атипической гиперплазии эндометрия. Практ онкол 2004;5(1):52–9.
8. Wheeler D., Bell K., Kurman R.J., Sherman M. Minimal uteri serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol 2000;24:797–806.
9. Zheng W., Khurana R., Farahmand S. et al. p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma. Am J Surg Pathol 1998;22:1463–73.
10. Emoto M., Tamura R., Shirota K. et al. Clinical usfullness of color Doppler ultrasound in patients with endometrial hyperplasia and carcinoma. Cancer 2002;94(3):700–6.
11. Wolfman W., Leviand N., Heywoood M. et al. Asymptomatic endometrial thickening. J Obstet Gynaecol Cancer 2009;32(10):990–9.
12. Fleischner A., Wheeler J., Lindsay I. et al. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Am J Obstet Gynecol 2001;184(2):70–5.
13. Ампилогова Э.Р. Оптимизация неинвазивной диагностики гиперпластических процессов и рака эндометрия. Автореф. дис. ... канд. мед. наук. М., 2007.
14. Wilailak S., Jurapinyo M., Theppisai U. Transvaginal Doppler sonography: is there a role this modality in evaluation of women with postmenopausal bleeding? Maturitas 2005;50(2):111–6.
15. Табакман Ю.Ю. Рак эндометрия. М., 2009; с. 32–46.
16. Arslan S., Gokmen O., Yuncay O. The office hysteroscopic evaluation of postmenopausal patients. Arh Gynecol Obstet 2004;270(1):31–3.
17. Eslandabesee D., Greenwood P. The per- formance of Pipelle endometrial sampling in a dedicated postmenopausal bleeding clinic. J Obstet Gynaecol 2005;25(1):32–4.
18. Suh-Burgmann E., Hung Y., Armstrong M. Complex atypical endometrial hyperplasia. The risk of unrecognized adenocarcinoma and value of preoperative dilatation and curettage. Obstet Gynaecol 2009;114:523–9.
Review
For citations:
Gornikh O.A., Samoilenko V.V., Bishtavi A.K., Kanibolotsky A.A., Manukhin I.B., Tabakman U.U. Hyperplasia and endometrial precancer. Tumors of female reproductive system. 2011;(4):59-63. https://doi.org/10.17650/1994-4098-2011-0-4-59-63
Email this article 